TopNews

Stock market analyst Kunal Saraogi is of the view that investors can sell Infosys Technologies Ltd stock to achieve a target of Rs 2460.

According to analyst, the investors can sell the stock with a stoploss of Rs 2640.

If the stock fell below Rs 2445, it may see more weakness.

After selling the stock, the interested investors can buy the stock again on declines for long term.

Today, the stock opened at Rs 2616 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 2875 and a low of Rs 1499 on BSE.

Last week, TV celebs Varun and Rajeshwari Badola were blessed with a baby boy after six years of marriage.

On this an elated Varun said, "Frankly speaking, the feeling is yet to sink in even after a week. I was blank then, and I'm blank now. Honestly, you really don't know what to say during such moments. Both the baby and the mother are in fine condition. Rajeshwari is with her parents now. The naming ceremony will take place 21 days after the child's birth."

According to a new research, wart cream may be helpful in treating recurrent outbreaks of skin cancer.

The wart cream has the powerful allergen diphencyprone (DPCP), and it is being utilized in an ongoing examination to propel the immune system of a person to attack melanomas.

Diona Damian, associate professor at the Sydney Cancer Centre made use of the wart cream on 18 cancer sufferers and the outcomes were positive as two-third of patients witnessed full clearance of their cancers.

Today, the 30-scrip sensitive index (Sensex) of the Bombay Stock Exchange (BSE) dropped from its opening peaks to rule 73 points up as against its last closure, about an hour into trade.

The Sensex, which belled the day 16,419.1, stood at 16,481.6, up 73.11 points (0.45%) from its previous close at 16,408.49.

At the National Stock Exchange (NSE), the broad-based Nifty remained up by 0.38% to trade at 4,938.35 from its previous close.

Broader markets remained flat, with the BSE midcap index trading 0.04% higher and the BSE smallcap index 0.28% up.

A novel research has disclosed that a new inhaler might one day cures impotency in just 10 minutes.

The newly discovered new inhaler has a powdered form of a drug named apomorphine that functions by arousing chemical receptors in the brain.

The drug apomorphine was created in order to cure Parkinson's disease, but scientists noticed it had a power to boost a man's desire.

Even though the new device is under trials, it could prove beneficial for males with ED if tests prove successful.

Researchers have provided new hope to cancer patients currently given no chance of survival - a 'magic bullet' cancer pill, which blasts away tumors.

The 'magic bullet' cancer pill, formulated from an undamaging bug, which can lead to stomach upsets, has been hailed as a major new weapon to fight cancer.

Early proof available from a trial, conducted in the UK on patients with advanced, untreatable cancers who had stopped benefiting from radiotherapy has seen remarkable results.